Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14564324 | 0.90 | ALDH1A1 (0.46) | L3MBTL1TDP1KMT2ARECQLALDH1A1 | |
| SCHEMBL107102 | 0.90 | ALDH1A1 (0.46) | L3MBTL1TDP1KMT2ARECQLALDH1A1 | |
| SCHEMBL14448181 | 0.90 | ALDH1A1 (0.46) | L3MBTL1TDP1KMT2ARECQLALDH1A1 | |
| SCHEMBL14491491 | 0.90 | ALDH1A1 (0.46) | L3MBTL1TDP1KMT2ARECQLALDH1A1 | |
| SCHEMBL13327360 | 0.86 | POLB (0.33) | POLBKMT2A | |
| SCHEMBL4831836 | 0.84 | — | — | |
| SCHEMBL4834444 | 0.83 | ALDH1A1 (0.36) | POLBTDP1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL11941653 | 0.80 | ALDH1A1 (0.38) | POLBL3MBTL1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL13135726 | 0.79 | PPM1B (0.36) | L3MBTL1TDP1SMN1; SMN2 | |
| SCHEMBL14448183 | 0.79 | ATM (0.42) | POLBALDH1A1ATMNPC1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180143546-A1 | METHOD FOR PRODUCING CURABLE LIQUID DEVELOPER | CANON KABUSHIKI KAISHA (JP) | 2018-05-24 | — | — | US | disclosed |